In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

  • A study by Dr. Gregory Abel showed the overall survival rates were the same in MDS patients age 60 to 65 years who received stem cell transplants compared to patients older than 66 years.

Tags: BasicResearch, StemCellTransplant

  • According to Dr. Ann Partridge, new findings suggest that as breast cancer continues to be better characterized molecularly, and therapies such as trastuzumab are developed, the importance of age with regard to prognosis will diminish.

Tags: BasicResearch, BreastCancer

  • Dana-Farber patient Anita Cutler met the bone marrow donor she credits with saving her life.

Tags: StemCellTransplant, Leukemia

  • This year’s WEEI/NESN Jimmy Fund Radio-Telethon raised over $3.3 million for patient care and cancer research at Dana-Farber. The two-day event featured personal stories of patients, clinical staff and researchers.

Tags: JimmyFund, Partnerships, RadioTelethon, Development

  • Dr. Ilana M. Braun comments on a new analysis that finds within two years of a cancer diagnosis, depression in patients and their spouses tends to drop back to roughly the same levels as in the general population, but is replaced by anxiety. 

Tags: BasicResearch, CopingWithCancer

  • Dr. Richard Stone joined 22 other specialists in sending a letter calling on the FDA to speed up the process allowing patients to use the leukemia drug Iclusig.

Tags: Leukemia

  • More than 30,000 people in Massachusetts work directly in biomedical research largely due to grants from the National Institutes of Health. Dr. Chuck Stiles is concerned for the future generation of researchers.

Tags: BasicResearch

  • Anyone who "likes" the Dana-Farber Facebook page before Nov. 1 will be entered in a contest to win a jersey signed by Red Sox slugger David Ortiz. 

Tags: BostonRedSox, JimmyFund, Partnerships, CopingWithCancer

  • Dr. Eric P. Winer co-chaired an expert panel that developed a clinical practice guideline on disease management for patients with advanced HER2-positive breast cancer and brain metastases.

Tags: BreastCancer

  • Dr. Monica Bertagnolli, chair of the Alliance for Clinical Trials in Oncology, remarked that efficiency has increased concerning patients entering clinical trials.

Tags: BasicResearch

Showing 21-30 of 425 items